ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,012.28
      -1.46%
      US Tech 100
      20,699.20
      0.64%
      Dow Jones
      44,713.58
      0.65%
      Brent Oil
      76.67
      0.52%
      Bitcoin
      102,729.33
      0.65%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Amneal Pharmaceuticals Inc (AMRX) Quote

      Amneal Pharmaceuticals Inc

      Amneal Pharmaceuticals Inc (AMRX)

      NASDAQ
      8.82
      0.14
      (1.61%)
      Closed January 27 4:00PM
      Delayed by 15 minutes
      8.82
      0.00
      ( 0.00% )
      Pre Market: 4:26AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      8.82
      Bid
      5.50
      Ask
      14.11
      Volume
      9
      0.00 Day's Range 0.00
      5.01 52 Week Range 9.475
      Market Cap
      2.733B
      Previous Close
      8.82
      Open
      -
      Last Trade
      2
      @
      8.72
      Last Trade Time
      04:25:21
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,176,903
      Shares Outstanding
      309,844,430
      Dividend Yield
      -
      PE Ratio
      -21.65
      Earnings Per Share (EPS)
      -0.27
      Revenue
      2.41B
      Net Profit
      -83.99M

      About Amneal Pharmaceuticals Inc

      Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.amneal.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMRX. The last closing price for Amneal Pharmaceuticals was $8.82. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of $ 5.01 to $ 9.475.

      Amneal Pharmaceuticals currently has 309,844,430 shares outstanding. The market capitalization of Amneal Pharmaceuticals is $2.73 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.65.

      Ask ADVFN Intelligence (AI)

      AMRX Latest News

      More News

      FeaturedLaFleur Minerals Provides Updates on Exploration at Swanson Gold Deposit and Plans to Restart of Beacon Gold Mill

      20 hours ago

      Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

      January 23 2025
      Edgar (US Regulatory)

      Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin

      Approval of three important therapies for dementia, oncology and gastrointestinal disease Granted 180-day exclusivity for memantine/donepezil extended-release capsules Tentative approval of...

      January 23 2025
      Business Wire

      Form 8-K - Current report

      January 15 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 10 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 06 2025
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      January 02 2025
      Edgar (US Regulatory)

      Amneal to Participate at Upcoming Investor Conferences

      Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos...

      December 04 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      November 26 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 25 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.485.755395683458.348.8558.2812310368.63136047CS
      40.9712.35668789817.858.8557.62511878198.14764125CS
      120.475.628742514978.359.4757.5211769038.31864688CS
      261.3818.54838709687.449.4756.511880328.25313849CS
      523.1856.38297872345.649.4755.0113202747.12231857CS
      1562.94505.889.4755.0113264447.00233413CS
      2602.94505.889.4755.0113264447.00233413CS

      AMRX - Frequently Asked Questions (FAQ)

      What is the current Amneal Pharmaceuticals share price?
      The current share price of Amneal Pharmaceuticals is $ 8.82
      How many Amneal Pharmaceuticals shares are in issue?
      Amneal Pharmaceuticals has 309,844,430 shares in issue
      What is the market cap of Amneal Pharmaceuticals?
      The market capitalisation of Amneal Pharmaceuticals is USD 2.73B
      What is the 1 year trading range for Amneal Pharmaceuticals share price?
      Amneal Pharmaceuticals has traded in the range of $ 5.01 to $ 9.475 during the past year
      What is the PE ratio of Amneal Pharmaceuticals?
      The price to earnings ratio of Amneal Pharmaceuticals is -21.65
      What is the cash to sales ratio of Amneal Pharmaceuticals?
      The cash to sales ratio of Amneal Pharmaceuticals is 0.75
      What is the reporting currency for Amneal Pharmaceuticals?
      Amneal Pharmaceuticals reports financial results in USD
      What is the latest annual turnover for Amneal Pharmaceuticals?
      The latest annual turnover of Amneal Pharmaceuticals is USD 2.41B
      What is the latest annual profit for Amneal Pharmaceuticals?
      The latest annual profit of Amneal Pharmaceuticals is USD -83.99M
      What is the registered address of Amneal Pharmaceuticals?
      The registered address for Amneal Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Amneal Pharmaceuticals website address?
      The website address for Amneal Pharmaceuticals is www.amneal.com
      Which industry sector does Amneal Pharmaceuticals operate in?
      Amneal Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BACKIMAC Holdings Inc
      $ 1.71
      (106.27%)
      		14.46M
      CDTConduit Pharmaceuticals Inc
      $ 5.55
      (68.18%)
      		231.25k
      FORLFour Leaf Acquisition Corporation
      $ 17.91
      (60.20%)
      		12
      GDSTGoldenstone Acquisition Ltd
      $ 18.55
      (59.09%)
      		18
      IROHIron Horse Acquisition Corporation
      $ 16.47
      (58.98%)
      		6
      TMCITreace Medical Concepts Inc
      $ 4.00
      (-58.76%)
      		197
      HCVIHennessy Capital Investment Corporation VI
      $ 6.01
      (-43.89%)
      		5
      CCECCapital Clean Energy Carriers Corporation
      $ 13.01
      (-29.68%)
      		8
      FSTRL B Foster Company
      $ 19.12
      (-29.21%)
      		14
      BLFSBioLife Solutions Inc
      $ 20.12
      (-28.85%)
      		8
      HEPAHepion Pharmaceuticals Inc
      $ 0.22
      (33.33%)
      		17.7M
      BACKIMAC Holdings Inc
      $ 1.71
      (106.27%)
      		14.46M
      YIBOPlanet Image International Ltd
      $ 4.84
      (57.14%)
      		7.43M
      ZKINZK International Group Co Ltd
      $ 1.05
      (54.41%)
      		6.89M
      NVDANVIDIA Corporation
      $ 124.56
      (5.18%)
      		5.33M

      Discussion

      View Full Feed
      facts_matter14 facts_matter14 4 minutes ago
      Hers the pitch; another swing and a miss……..

      Only needed 150% more revenue to be right about this pump.





      https://investorshub.advfn.com/uimage/uploads/2025/1/26/czcimIMG_6273.jpeg



      https://investorshub.advfn.
      SRMX
      mahatmapaul mahatmapaul 5 minutes ago
      This post of Kool Aid's should be stickied!
      SPZI
      oldstocks oldstocks 6 minutes ago
      He has made business decisions building the casinos that a lot of companies in Atlantic County lost a lot of money on including my family. He is best in his position now. Given the choices of voting options a lot of them same people voted for him hoping he can make America better.
      We do not
      AFFU
      chicks0123 chicks0123 8 minutes ago
      Good morning CLNVERS 
      CLNV
      ArcCeliaSkye ArcCeliaSkye 8 minutes ago
      He has been deceiving everyone here, and this fraud is happening in broad daylight, yet no one is making an effort to hold him accountable or put him behind bars. Are we so indifferent that we allow this man to exploit the hard-earned money of investors and drain the livelihood and well-being of emp
      ITUP
      glenn1919 glenn1919 9 minutes ago
      athe................................https://stockcharts.com/h-sc/ui?s=athe&p=W&b=5&g=0&id=p86431144783
      ATHE
      MartinLutherKing MartinLutherKing 9 minutes ago
      Green light fast track 🚀🚀🚀TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
      April 15 2024 - 9:00AM


      Share On Facebook

      TransCode Therapeutics, In
      RNAZ
      JSmith5 JSmith5 11 minutes ago
      Don't have a choice to show the bird to the folks who has to approve his selection

      Exactly! We don't want to go to the tie-breaker again. He will respond with the exact same answers as did Treasury as the response is being prepared by the same members of the Transition team. They w
      FNMA
      SkeBallLarry SkeBallLarry 11 minutes ago
      US Border Patrol and Mexican cartel members trade >

      gunfire at southern border: report >
      https://nypost.com/2025/01/28/us-news/us-border-patrol-and-mexican-cartel-members-trade-gunfire-at-southern-border-report/
      SkeBallLarry SkeBallLarry 12 minutes ago
      US Border Patrol and Mexican cartel members trade >

      gunfire at southern border: report >
      https://nypost.com/2025/01/28/us-news/us-border-patrol-and-mexican-cartel-members-trade-gunfire-at-southern-border-report/
      SkeBallLarry SkeBallLarry 13 minutes ago
      US Border Patrol and Mexican cartel members trade >

      gunfire at southern border: report >
      https://nypost.com/2025/01/28/us-news/us-border-patrol-and-mexican-cartel-members-trade-gunfire-at-southern-border-report/
      facts_matter14 facts_matter14 13 minutes ago
      WOW, this is INCREDIBLE!!

      On 8-21-21, pps was .0014

      41 months later, what a BLAST OFF it was!!

      Wasn’t very little selling, it was very little buying. Duh!







      https://investorshub.advfn.com/uimage
      SRMX
      SkeBallLarry SkeBallLarry 13 minutes ago
      US Border Patrol and Mexican cartel members trade >

      gunfire at southern border: report >
      https://nypost.com/2025/01/28/us-news/us-border-patrol-and-mexican-cartel-members-trade-gunfire-at-southern-border-report/
      sab63090 sab63090 14 minutes ago
      Yes on BDX, but sorry for our Bills...Cook did well, Allen, too, but only used Shakir for a good play....it was close except for some mistakes...next year
      BDX
      SkeBallLarry SkeBallLarry 14 minutes ago
      US Border Patrol and Mexican cartel members trade >

      gunfire at southern border: report >
      https://nypost.com/2025/01/28/us-news/us-border-patrol-and-mexican-cartel-members-trade-gunfire-at-southern-border-report/
      Number sleven Number sleven 16 minutes ago
      https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amarin-pharma-inc/?page=2
      Sleven,
      AMRN
      allezlOM allezlOM 24 minutes ago
      $DBMM , you could be true ➡️"13f-2's compliance date is Jan 2, 2025. The initial report required by Rule 13f-2, which will cover gross short positions that exceeded the applicable threshold during January 2025 (which may include gross short positions entered into prior to January 2025), is due Feb.
      DBMM
      sab63090 sab63090 25 minutes ago
      I'm caught up on this board now...so I will now observe for some later day trades to see where I might be right or wrong...🤔
      AVXL
      hedges54 hedges54 27 minutes ago
      towards the end of Core Chronicles 7 he mentioned that there was going to be an announcement that was going to be on Blomberg FOX CBS NBC etc. but could not mention it yet because of confidenceality .I hope that comes up again soon
      ARAT
      sab63090 sab63090 28 minutes ago
      Steady T
      I not only agree, but you might consider that when the stock is strong that they take advantage and actually buy and enhance the up move to get short again using the advantage of the delayed calendar reporting; tactfully using that...those chief traders know all the tricks.
      MCD WMT
      eagle8 eagle8 28 minutes ago
      Frank Nez
      @FNez_Blogger
      ·
      12h
      🚨JUST IN: CFO of Massive Hedge Fund Will Now Serve 8 Years in Prison
      https://franknez.com/cfo-of-massive-hedge-fund-will-now-serve-8-years-in-prison/
      NWBO

      Your Recent History

      NASDAQ
      AMRX
      Amneal Pharmaceuticals
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads